Sort by
Refine Your Search
-
the ability of the mono-ADP-ribosyltransferase, Parp7 and Parp11, at improving check point inhibition therapy in intraductal mammary tumour models. More about the position Research activities will take place in
-
Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System. J Med Chem. 2020). The lessons learned from the validation shall also be used to develop improved methods. About the LEAD
Searches related to model checking
Enter an email to receive alerts for model-checking positions